The Foundation for the National Institutes of Health announced the release of a draft guidance by the Food and Drug Administration on a new breast cancer drug trial design.
The new approach would reduce the time and cost of bringing new treatments to patients.
Click here to read the full story in Becker's Hospital Review on the FDA.
The new approach would reduce the time and cost of bringing new treatments to patients.
Click here to read the full story in Becker's Hospital Review on the FDA.
